Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience

被引：0

作者：

Johansen, Kirsten L. ^{[1
]}

Acharya, Anjali ^{[2
]}

Cizman, Borut ^{[3
]}

Cobitz, Alexander R. ^{[3
]}

Correa-Rotter, Ricardo ^{[4
]}

Dasgupta, Indranil ^{[5
,6
]}

Kher, Vijay ^{[7
]}

Lopes, Renato D. ^{[8
]}

Matsumoto, Leonardo ^{[9
]}

Meadowcroft, Amy M. ^{[3
]}

Merege Vieira Neto, Osvaldo ^{[10
]}

Okabe, Marilu ^{[9
]}

Rayner, Brian ^{[11
]}

Silva, Arnold ^{[12
]}

Thomas, Hilary ^{[9
]}

Singh, Ajay K. ^{[13
,14
]}

机构：

[1] Univ Minnesota, Hennepin Healthcare, 730 South 8th St, Minneapolis, MN 55415 USA

[2] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10461 USA

[3] GlaxoSmithKline, Collegeville, PA USA

[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[5] Heartlands Hosp, Birmingham, W Midlands, England

[6] Univ Warwick, Coventry, W Midlands, England

[7] Medanta Kidney & Urol Inst, Medanta Med, Gurgaon, India

[8] Duke Hlth, Duke Clin Res Inst, Durham, NC USA

[9] PPD Worldwide Headquarters, Wilmington, NC USA

[10] Serv Nefrol Ribeirao Preto, Sao Paulo, Brazil

[11] Groote Schuur Hosp, Cape Town, South Africa

[12] Boise Kidney & Hypertens Inst, Meridian, ID USA

[13] Brigham & Womens Hosp, Boston, MA 02115 USA

[14] Harvard Med Sch, Boston, MA 02115 USA

来源：

KIDNEY360 | 2022年 / 3卷 / 04期

关键词：

chronic kidney disease; clinical trial; COVID-19; dialysis; pandemics; SARS-CoV-2;

D O I：

10.34067/KID.0006212021

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Key Points The coronavirus disease 2019 pandemic has had an unprecedented effect on health and health care and posed challenges to the conduct of clinical trials. Targeted mitigating strategies, on the basis of early and continued data collection from site surveys, limited disruption to the ASCEND trials. Flexibly allowing hemoglobin assessment at local laboratories to inform randomized treatment dosing was key to limiting the discontinuation of treatment.

引用

页码：728 / 733

页数：6

共 50 条

[21] The SARS-COV-2 pandemic and the challenges of intellectual property rights
Lukinovic, Mario
Vitosevic, Zdravko
[J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2021, 149 (7-8) : 511 - 515
[22] Challenges and experiences of the SARS-CoV-2 pandemic in molecular diagnostics
Andras, Zoka
Balint, Treso
Gabriella, Beko
[J]. ORVOSI HETILAP, 2021, 162 (52) : 2071 - 2078
[23] A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Tu, Yung-Fang
Chien, Chian-Shiu
Yarmishyn, Aliaksandr A.
Lin, Yi-Ying
Luo, Yung-Hung
Lin, Yi-Tsung
Lai, Wei-Yi
Yang, De-Ming
Chou, Shih-Jie
Yang, Yi-Ping
Wang, Mong-Lien
Chiou, Shih-Hwa
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (07)
[24] Clinical Trials of Repurposed Antivirals for SARS-CoV-2
Angel Martinez, Miguel
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
[25] Challenges and solutions for opioid dependence therapy during the SARS-COV-2 pandemic in Germany
Poehlke, Thomas
[J]. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2022, 24 (03) : 41 - 45
[26] Pulmonary embolism during SARS-CoV-2 pandemic: clinical and radiological features
Garcia-Lledo, A.
del Palacio-Salgado, M.
Alvarez-Sanz, C.
Perez-Gil, M. M.
Cruz-Diaz, A.
[J]. REVISTA CLINICA ESPANOLA, 2022, 222 (06): : 354 - 358
[27] Clinical impact of delaying ocrelizumab infusions during the SARS-COV-2 pandemic
Smoot, K.
Stuchiner, T.
Chen, C.
Grote, L.
Brink, J.
Cohan, S.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 553 - 553
[28] Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic
Abu-Raya, Bahaa
Gantt, Soren
Sadarangani, Manish
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (34) : E982 - E985
[29] Kawasaki Disease During the SARS-CoV-2 Pandemic
Goyal, Anisha
Maheshwari, Anu
Shakeel, Adiba
Saneja, Vipul
Kumar, Sarvesh
Mahto, Deonath
[J]. INDIAN JOURNAL OF PEDIATRICS, 2022, 89 (11): : 1157 - 1157
[30] Critical Operations During the SARS-CoV-2 Pandemic
Karaca, Olga
Rueggeberg, Joerg-Andreas
Bialas, Enno
Schuster, Martin
[J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (33-34): : 558 - 559

← 1 2 3 4 5 →